Rabbit/Goat RFC1 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Navigation Links
Rabbit/Goat RFC1 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
| Products | Rabbit/Goat RFC1 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories |
| Company | Bethyl Laboratories |
| Item | Rabbit/Goat RFC1 AbVantage Pack Polyclonal Antibody, Unconjugated |
| Price | $325.00 |
| Description | Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support. |
| Info |  Bethyl LaboratoriesBethyl Laboratories P.O. Box 850 Montgomery, TX 77356 Customer Service: 800-338-9579 Fax Number: 936-597-6105 Web Site: http://www.bethyl.com |
NOTE: Price information is approximate list price and actual prices may vary.
Related biology products :
1. Rabbit anti-UBAP2L/NICE4 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
2. Rabbit anti-USP33 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
3. Rabbit anti-XLF AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
4. Rabbit anti-QKI AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
5. Rabbit anti-PPP1C AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
6. Rabbit anti-JLP AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
7. Rabbit anti-Alpha-4 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
8. Goat Anti-TGase3 (S-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
9. Rabbit Anti-Aph-1aL, S Loop (92-115) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc
10. Goat Anti-SCCRO (S-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
11. Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Breaking Biology News(10 mins):Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Stem cells battle for space 2Right to Health Care Debated at New ProCon org Website 58181 1Right to Health Care Debated at New ProCon org Website 58181 2R Kerry Clark and Robert J Palmisano Join Bausch 26 Lomb Board of Directors 58179 1R Kerry Clark and Robert J Palmisano Join Bausch 26 Lomb Board of Directors 58179 2Compendia Bioscience Announces the Release of Oncomine 4 Research Edition 14240 1Compendia Bioscience Announces the Release of Oncomine 4 Research Edition 14240 2
Other Biology News:Tiny invasive snail impacts Great Lakes, alters ecology 2Tiny invasive snail impacts Great Lakes, alters ecology 3Pacific shellfish ready to invade Atlantic 2TORC at UH turns to virtual world of Second Life for new study 2
Breaking Biology Technology:Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2Alberta companies delivering new products to the health & medical marketplace 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4
[0] Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A[0] WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening[0] Alberta companies delivering new products to the health & medical marketplace[0] Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |